English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Annexin V-Modified Platelet-Biomimetic Nanomedicine for Targeted Therapy of Acute Ischemic Stroke Journal article
Quan, Xingping, Han, Yan, Lu, Pengde, Ding, Yuanfu, Wang, Qingfu, Li, Yiyang, Wei, Jianwen, Huang, Qiaoxian, Wang, Ruibing, Zhao, Yonghua. Annexin V-Modified Platelet-Biomimetic Nanomedicine for Targeted Therapy of Acute Ischemic Stroke[J]. Advanced Healthcare Materials, 2022, 11(16), 2200416.
Authors:  Quan, Xingping;  Han, Yan;  Lu, Pengde;  Ding, Yuanfu;  Wang, Qingfu; et al.
Favorite | TC[WOS]:22 TC[Scopus]:23  IF:10.0/11.3 | Submit date：2022/08/05
Acute Ischemic Stroke  Annexin v  Phosphatidylserine  Platelet Biomimetic  Tissue Plasminogen Activator  
Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke Journal article
Liu, Bowen, Li, Yiyang, Han, Yan, Wang, Shengpeng, Yang, Hua, Zhao, Yonghua, Li, Ping, Wang, Yitao. Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke[J]. PHYTOMEDICINE, 2021, 90, 153660.
Authors:  Liu, Bowen;  Li, Yiyang;  Han, Yan;  Wang, Shengpeng;  Yang, Hua; et al.
Favorite | TC[WOS]:44 TC[Scopus]:47  IF:6.7/6.2 | Submit date：2021/09/13
Acute Ischemic Stroke  Blood-brain Barrier  Caveolin1/mmp2/9 Pathway  Notoginsenoside R1  Tight Junctions